Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Revenue | -80.00% | 150.00% | -21.98% | 432.48% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -80.00% | 150.00% | -21.98% | 432.48% | -- |
| Cost of Revenue | -100.00% | 100.00% | -69.49% | 136.84% | -- |
| Gross Profit | 0.00% | 200.00% | 35.40% | 982.93% | -- |
| SG&A Expenses | -14.36% | -31.15% | -20.44% | 532.89% | -16.74% |
| Depreciation & Amortization | -54.79% | -15.65% | -1.88% | 208.16% | 135.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.60% | -5.75% | -15.12% | 0.00% | -6.38% |
| Operating Income | 3.95% | 5.90% | 11.04% | 31.51% | 7.18% |
| Income Before Tax | 3.17% | 9.82% | -169.59% | 21.96% | 3.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.17% | 9.82% | -169.59% | 21.96% | 3.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.17% | 9.82% | -169.59% | 21.96% | 3.62% |
| EBIT | 3.95% | 5.90% | 11.04% | 31.51% | 7.18% |
| EBITDA | 3.47% | 5.84% | 10.58% | 31.92% | 5.62% |
| EPS Basic | 3.45% | 10.00% | -166.67% | 22.22% | 6.45% |
| Normalized Basic EPS | 0.00% | 10.53% | -150.00% | 22.73% | 5.26% |
| EPS Diluted | 3.45% | 10.00% | -166.67% | -- | 6.45% |
| Normalized Diluted EPS | 0.00% | 10.53% | -150.00% | 22.73% | 5.26% |
| Average Basic Shares Outstanding | 0.36% | 0.41% | 0.50% | 0.51% | 0.50% |
| Average Diluted Shares Outstanding | 0.36% | 0.52% | 0.61% | 0.51% | 0.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
